We are live on
!
Find out more
OP
Omni Partners Portfolio holdings
AUM
$2.03B
1-Year Est. Return
126.33%
This Fund
S&P 500
This Quarter
Est. Return
+42.43%
1 Year Est. Return
+126.33%
3 Year Est. Return
+411.65%
5 Year Est. Return
+1,549.93%
10 Year Est. Return
–
AUM
$846M
AUM Growth
-$289M
(-25%)
Cap. Flow
-$395M
Cap. Flow
% of AUM
-46.62%
Top 10 Holdings %
Top 10 Hldgs %
70.78%
Holding
88
New
25
Increased
9
Reduced
24
Closed
29
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
LN
LINE Corporation
LN
|
+$59.5M |
| 2 |
CZR
Caesars Entertainment Corporation
CZR
|
+$53.8M |
| 3 |
WMGI
Wright Medical Group Inc
WMGI
|
+$47.1M |
| 4 |
PTLA
Portola Pharmaceuticals, Inc.
PTLA
|
+$44.7M |
| 5 |
WUBA
58.com Inc
WUBA
|
+$33M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$145M |
| 2 |
LOGM
LogMein, Inc.
LOGM
|
+$81.8M |
| 3 |
TIF
Tiffany & Co.
TIF
|
+$78.6M |
| 4 |
CY
Cypress Semiconductor
CY
|
+$75.6M |
| 5 |
S
Sprint Corporation
S
|
+$62.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 32.51% |
| 2 | Consumer Discretionary | 15.9% |
| 3 | Healthcare | 12.99% |
| 4 | Industrials | 9.3% |
| 5 | Communication Services | 7.95% |
Similar funds
BUB
PAG
SBSB
PPCM
AAM
ALSV
TNB
FIB
Omni Partners's Q2 2020 Portfolio in Review
As of Q2 2020, Omni Partners held 88 positions worth $846M, down 25% from $1.14B the previous quarter. Its ten largest holdings account for 71% of the portfolio.
Omni Partners withdrew a net $395M in Q2 2020, closing 29 positions and reducing 24 holdings. Its most notable exit was Allergan plc, an estimated $145M position sold in full.
By sector, the portfolio is most concentrated in Financials at 33% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Omni Partners opened a new position in LINE Corporation worth $60.5M.
- Omni Partners's largest Q2 2020 buy was LINE Corporation: 1,204,776 shares worth $60.5M.
- Omni Partners added most to Caesars Entertainment Corporation in Q2 2020, an estimated $53.8M increase.
- Omni Partners's biggest Q2 2020 reduction was Tiffany & Co., cutting an estimated $78.6M.
- Omni Partners fully exited Allergan plc in Q2 2020, selling an estimated $145M.
- Omni Partners's ten largest holdings make up 71% of its $846M portfolio in Q2 2020.
- Omni Partners opened 25 new positions and closed 29 in Q2 2020.
- Omni Partners's portfolio value fell 25% quarter-over-quarter to $846M.
Based on Omni Partners's 13F filing for Q2 2020, filed 14 Aug 2020.